Effect of Radiotherapy on Functional and Health-Related Quality of Life Outcomes after Jaw Reconstruction.
head and neck cancer
jaw reconstruction
osteoradionecrosis
quality of life
speech
swallowing
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
20 Sep 2022
20 Sep 2022
Historique:
received:
22
08
2022
revised:
12
09
2022
accepted:
16
09
2022
entrez:
14
10
2022
pubmed:
15
10
2022
medline:
15
10
2022
Statut:
epublish
Résumé
Long-term health-related quality of life (HRQOL) and functional outcomes following mandibular and maxillary reconstruction are lacking. To determine these outcomes, a cross-sectional study of patients with a history of cancer who underwent jaw reconstruction was undertaken. Participants were identified from a database of jaw reconstruction procedures at the Chris O'Brien Lifehouse (Sydney, Australia). Eligible patients had at least one month follow-up, were aged ≥18 years at surgery, and had history of malignancy. HRQOL was measured using the FACE-Q Head and Neck Cancer Module (FACE-Q H&N). Functional outcomes were measured using the FACE-Q H&N, MD Anderson Dysphagia Inventory (MDADI) and Speech Handicap Index (SHI). Ninety-seven questionnaires were completed (62% response rate). Mean age of respondents was 63.7 years, 61% were male, and 64% underwent radiotherapy. Treatment with radiotherapy was associated with worse outcomes across 10/14 FACE-Q H&N scales, three MDADI subscales and one composite score, and the SHI. Mean differences in scores between irradiated and non-irradiated patients exceeded clinically meaningful differences for the MDADI and SHI. Issues with oral competence, saliva, speaking, and swallowing worsened with increasing time since surgery. Younger patients reported greater concerns with appearance, smiling, speaking, and cancer worry. Women reported greater concerns regarding appearance and associated distress. History of radiotherapy substantially impacts HRQOL and function after jaw reconstruction. Age at surgery and gender were also predictors of outcomes and associated distress. Pre-treatment counselling of patients requiring jaw reconstruction may lead to improved survivorship for patients with head and neck cancer.
Identifiants
pubmed: 36230477
pii: cancers14194557
doi: 10.3390/cancers14194557
pmc: PMC9559672
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Cancer Institute of New South Wales
ID : 2020TPG1081
Organisme : Sydney Local Health District
ID : N/A
Organisme : Lang Walker Family Foundation
ID : N/A
Références
Lancet. 2021 Dec 18;398(10318):2289-2299
pubmed: 34562395
Curr Opin Otolaryngol Head Neck Surg. 2020 Jun;28(3):155-160
pubmed: 32345920
Laryngoscope. 2016 May;126(5):1108-13
pubmed: 26542529
Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Aug;124(2):139-145
pubmed: 28606831
Head Neck. 2013 Nov;35(11):1599-605
pubmed: 23150453
Oncologist. 2010;15(9):994-1001
pubmed: 20798198
Radiat Oncol. 2021 Jan 5;16(1):1
pubmed: 33402192
Cancer Pract. 1999 Nov-Dec;7(6):309-13
pubmed: 10732529
Oral Oncol. 2017 Jan;64:44-51
pubmed: 28024723
Cancer. 2019 Mar 15;125(6):863-872
pubmed: 30500993
Br J Oral Maxillofac Surg. 2012 Sep;50(6):481-9
pubmed: 22196145
JAMA Otolaryngol Head Neck Surg. 2018 Aug 1;144(8):753-754
pubmed: 29978188
Head Neck. 2011 Apr;33(4):458-68
pubmed: 20652979
Head Neck. 2008 Jul;30(7):868-74
pubmed: 18302270
Ann R Coll Surg Engl. 2004 Nov;86(6):407-10
pubmed: 15527574
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Jan;113(1):54-69
pubmed: 22669065
Br J Oral Maxillofac Surg. 2022 Feb;60(2):168-173
pubmed: 34857411
Braz J Otorhinolaryngol. 2021 Jul 30;:
pubmed: 34407916
Oral Oncol. 2017 Sep;72:98-103
pubmed: 28797468
J Oral Maxillofac Surg. 2012 Jan;70(1):216-20
pubmed: 21820228
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Arch Otolaryngol Head Neck Surg. 2007 May;133(5):464-70
pubmed: 17520760
Nat Rev Dis Primers. 2020 Nov 26;6(1):92
pubmed: 33243986
Cancer. 2017 Oct 1;123(19):3691-3700
pubmed: 28608925
Plast Reconstr Surg Glob Open. 2019 Sep 30;7(9):e2423
pubmed: 31942391
J Laryngol Otol. 2016 May;130(S2):S191-S197
pubmed: 27841135
Cancer. 2013 Jul 1;119(13):2427-37
pubmed: 23576156
Int J Oral Maxillofac Surg. 2021 Feb;50(2):143-150
pubmed: 32616305
Head Neck. 2012 Feb;34(2):207-12
pubmed: 21584893
Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):870-6
pubmed: 11448365
Support Care Cancer. 2017 Aug;25(8):2413-2420
pubmed: 28258504
J Craniofac Surg. 2016 Mar;27(2):e172-5
pubmed: 26845095
Sci Rep. 2020 May 12;10(1):7877
pubmed: 32398670
JAMA Otolaryngol Head Neck Surg. 2021 Dec 1;147(12):1035-1044
pubmed: 34292310
Microsurgery. 2013 Jul;33(5):337-41
pubmed: 23568609
Head Neck. 2018 Jan;40(1):46-54
pubmed: 29149496
Int J Oral Maxillofac Surg. 2013 Sep;42(9):1121-8
pubmed: 23643291
Cancer. 2017 Jun 1;123(11):1949-1957
pubmed: 28081302
Adv Med. 2014;2014:795483
pubmed: 26556426
Acta Oncol. 2019 Oct;58(10):1373-1377
pubmed: 31364903
Oral Oncol. 2006 Aug;42(7):726-34
pubmed: 16529976
Head Neck. 2017 Jul;39(7):1399-1404
pubmed: 28452199
Head Neck. 2019 Jun;41(6):1935-1942
pubmed: 30801885
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):415-20
pubmed: 22795804